Did you know? In Southeast Asia, there are over 1.7 million new cancer patients annually, with over 70% of patients diagnosed in the late stage, which is often untreatable. Early cancer detection increases survival rates by 90-95%. Additionally, data from the World Health Organization predicts a 45% increase in cancer-related deaths by 2573. Since cancer is often detected in later stages, treatment becomes difficult and financially burdensome for patients and families.
For further information or Booking..
Screen with SPOT-MAS, know before, and increase cancer survival rates.
Cancer originates from mutations. Identifying these mutations helps doctors choose the best treatment for patients. Screening with SPOT-MAS detects circulating tumor DNA (ctDNA), genetic material released by cancer cells in the bloodstream, using Next-generation sequencing technology. This method screens for multiple types of cancer from the early stages in asymptomatic individuals with just one blood draw. It’s a technology developed to address the cancer needs of the Southeast Asian population.
SPOT-MAS detects 5 types of early-stage cancer in one go.
SPOT-MAS can screen for up to 5 types of cancer, including liver, breast, lung, colorectal, and stomach cancer, with just one blood test.
Advantages of SPOT-MAS cancer screening:
- Easy and minimally invasive with just one blood draw
- No need for various tissue samples or invasive procedures
- High accuracy and specificity of 95.9%
- Results available within 30 days
Who is SPOT-MAS suitable for?
- Individuals aged 40 and above, as recommended by the WHO for cancer screening, similar to regular health check-ups, to detect early cell abnormalities due to the higher risk of various cancers at this age.
- Those at high risk of cancer, such as long-term smokers, regular alcohol drinkers, individuals exposed to carcinogens, or living in areas with a high risk of cancer, such as PM2.5 pollutions.
- Anyone seeking cancer screening, starting from age 18.
For further information or Booking..